
Infinant Health
Our mission is to change the trajectory of human health, one baby at a time.
Sacramento, United States · Founded 2011 · $125.0M raised
- Headquarters
- Sacramento, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B2C
- Website
- infinanthealth.com
- Total Funding
- $125.0M
- Last Round
- $55.0M Series DFeb 2021
- Rounds
- 5
About
Infinant Health is a clinical-stage biotechnology company developing live biotherapeutic products focused on the infant gut microbiome. Its lead candidate, INF108, is a next-generation B. infantis drug strain designed to prevent necrotizing enterocolitis (NEC) in premature infants. The company's research builds on the relationship between breast milk, B. infantis, and early immune development to establish a healthier foundation for lifelong health.
Summary
Infinant Health is a Healthcare company based in Sacramento, United States, founded in 2011. It has raised $125.0M in total across 5 rounds, most recently a $55.0M Series D round in Feb 2021. Investors include Horizons Ventures, Cargill and Bill & Melinda Gates Foundation.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors

Horizons Ventures
2 rounds

Cargill
1 round
Bill & Melinda Gates Foundation
1 round
Li Ka Shing Foundation
1 round

Spruce Capital Partners/MLS
1 round
Tate & Lyle Ventures
3 rounds
Manna Tree Partners
1 round

Johnson & Johnson Innovation
1 round
Arla Foods
1 round
Continental
1 round

Bow Capital
1 round
Acre Venture Partners
1 round
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...